Stockhouse.com uses cookies on this site. By continuing to use our service, you agree to our use of cookies. Cookies are used to offer you a better browsing experience and to analyze our traffic. We also use them to share usage information with our partners. See full details.
I Agree
×
Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Privacy Policy | Disclaimer

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Privacy Policy | Disclaimer
Please Try Again {{ error }}

Send my password

Return to Login
SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Bullboard - Stock Discussion Forum Appili Therapeutics Inc APLIF


Primary Symbol: T.APLI

Healthcare
Appili Therapeutics Inc. is a Canada-based biopharmaceutical company focused on drug development for infectious diseases and medical countermeasures. The Company is advancing a diverse range of anti-infectives, including ready-made suspension of metronidazole for the treatment of antimicrobial infections, a vaccine candidate to eliminate a serious biological weapon threat, and a topical... see more

Bullboard (TSX:APLI)

View:
Prev 1 2 3 4 5 6 Next
Comment by shooter300on Feb 09, 2021 10:18am

RE:More Dilutioncoming...

Nothing will happen before before public offering.
129
Discussion
Post by stochastics1on Feb 05, 2021 7:18am

Appili Therapeutics Target $2.75

Halifax-based infectious disease drug developer Appili Therapeutics (TSX:APLI) received a coverage initiation from Leede Jones Gable analyst Douglas W. Loe on Wednesday, with the analyst starting ...more  
390
Post by calgarydaveon Jan 29, 2021 6:22am

WRONG . WRONG. WRONG.

Why were they even in a Trial to test Avigan for MODERATE TO SEVERE SYMPTOMS. This drug has been proven in many reliable trials in Asia in 2020 to not work for those symptoms. The drug works almost ...more  
360
Post by TheBearInTheWoodson Jan 27, 2021 12:00pm

There goes Avigan

[url=https://www.google.ca/amp/s/www.ndtv.com/business/dr-reddys-completes-review-of-covid-19-drug-avigan-in-kuwait-2358888%3famp=1&akamai-rum=off]https://www.google.ca/amp/s/www.ndtv.com/business ...more  
233
Post by Rossaporinoon Jan 01, 2021 9:30pm

Happy new year Do your Own DD

https://www.globenewswire.com/news-release/2020/12/31/2151927/0/en/MedMira-Announces-Product-Update.html
154
Comment by TheBearInTheWoodson Dec 30, 2020 11:37pm

RE:We need to fast-track this and where is our contract.

It is difficult to see through the Covid pump of the second quarter when everyone shifted from Cancer , Cronic Cough etc to Covid for the market impact. I know the Federal government has only invested ...more  
257
Discussion
Post by calgarydaveon Dec 20, 2020 6:45am

We need to fast-track this and where is our contract.

So we are sponsoring these trials as a member of a consortium.  There has never been any mention of how we benefit financially from this activity.  We are testing in USA and Canada and ...more  
295
Discussion
Post by TheBearInTheWoodson Dec 15, 2020 12:47pm

Arch Receives a gov grant

[url=https://https://www.canada.ca/en/innovation-science-economic-development/news/2020/12/government-of-canada-invests-in-promising-treatment-that-could-fight-covid-19.html]https://www.canada.ca/en ...more  
158
Post by BC2000on Dec 02, 2020 2:14pm

APLI the next to explode in the 3rd Phase announcement

Appili is sponsoring three randomized, double-blind, placebo-controlled clinical studies to determine the safety and effectiveness of Avigan tablets in outpatients in multiple COVID-19 indications ...more  
374
Post by BC2000on Nov 17, 2020 1:56pm

APLI Technicals Ready For A Rally On Any Positive News

 Appili Therapeutics Inc. Accumulate On Pullback After Financials “As the world enters the next wave of COVID-19 infections, our antiviral programs are steadily advancing. We were very pleased ...more  
874
Post by mattusvion Nov 02, 2020 9:37am

Apellis to dose first patient in Phase 2 MERIDIAN study.

Apellis expects to dose first patient in Phase 2 MERIDIAN study by year-end In October 2020, Apellis announced the initiation of registrational programs of pegcetacoplan in patients with immune ...more  
171
Post by calgarydaveon Oct 04, 2020 6:31am

Stock Price up 100% in a month and not a tweet on this board

No news since they moved to TSX but the price has moved dramatically and is moving close to all time high of $1.80. My call is that they are getting close to a licencing agreement with Fujifilm for ...more  
438
Prev 1 2 3 4 5 6 Next
The Market Update
{{currentVideo.title}} {{currentVideo.relativeTime}}
< Previous bulletin
Next bulletin >

At the Bell logo
A daily snapshot of everything
from market open to close.

{{currentVideo.companyName}}
{{currentVideo.intervieweeName}}{{currentVideo.intervieweeTitle}}
{{currentVideo.headline}}
{{currentVideo.link1Text}}
{{currentVideo.link2Text}}
< Previous
{{moreVideoText}}
Next >
Dealroom for high-potential pre-IPO opportunities